On Monday Pfizer filed an antitrust lawsuit against Danish pharmaceutical company Novo Nordisk alleging that Novos 9 billion bid for biotech firm Metsera is a calculated move to hinder competition in the obesity drug sector Pfizer had earlier agreed to a 73 billion acquisition of Metsera which is developing a promising new obesity drug
